Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Antibodies, Neutralizing (immunology) - Hemagglutinin Glycoproteins, Influenza Virus (immunology)

Terms

14Antibodies, Neutralizing (immunology)
27Hemagglutinin Glycoproteins, Influenza Virus (immunology)
34Hemagglutinin Glycoproteins, Influenza Virus (genetics)
40Antibodies, Viral (immunology)
68Influenza, Human (immunology)
21Hemagglutinin Glycoproteins, Influenza Virus (chemistry)
21Hemagglutinin Glycoproteins, Influenza Virus (metabolism)
44Vaccination

Associations

Freq.WeightAssociation
100.514Antibodies, Neutralizing (immunology) - Hemagglutinin Glycoproteins, Influenza Virus (immunology)
150.495Hemagglutinin Glycoproteins, Influenza Virus (genetics) - Hemagglutinin Glycoproteins, Influenza Virus (immunology)
110.465Antibodies, Neutralizing (immunology) - Antibodies, Viral (immunology)
150.456Antibodies, Viral (immunology) - Hemagglutinin Glycoproteins, Influenza Virus (immunology)
210.403Antibodies, Viral (immunology) - Influenza, Human (immunology)
100.476Hemagglutinin Glycoproteins, Influenza Virus (chemistry) - Hemagglutinin Glycoproteins, Influenza Virus (metabolism)
100.374Hemagglutinin Glycoproteins, Influenza Virus (chemistry) - Hemagglutinin Glycoproteins, Influenza Virus (genetics)
90.337Hemagglutinin Glycoproteins, Influenza Virus (genetics) - Hemagglutinin Glycoproteins, Influenza Virus (metabolism)
130.303Hemagglutinin Glycoproteins, Influenza Virus (immunology) - Influenza, Human (immunology)
140.256Influenza, Human (immunology) - Vaccination

Documents par ordre de pertinence
000E67 (2010) Chih-Jen Wei [États-Unis] ; Jeffrey C. Boyington ; Patrick M. Mctamney ; Wing-Pui Kong ; Melissa B. Pearce ; Ling Xu ; Hanne Andersen ; Srinivas Rao ; Terrence M. Tumpey ; Zhi-Yong Yang ; Gary J. NabelInduction of broadly neutralizing H1N1 influenza antibodies by vaccination.
000420 (2016) Nachiket Shembekar [Inde] ; Vamsee V Aditya Mallajosyula [Inde] ; Ankita Malik [Inde] ; Ashok Saini [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses.
000724 (2014) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Xing Cheng [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Marlene Orandle [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Three Live Attenuated H2 Pandemic Influenza Vaccine Candidates in Mice and Ferrets
000750 (2014) Arkadiusz Wyrzucki [Suisse] ; Cyrille Dreyfus [États-Unis] ; Ines Kohler [Suisse] ; Marco Steck [Suisse] ; Ian A. Wilson [États-Unis] ; Lars Hangartner [Suisse]Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic Antibody
000923 (2013) Rui Xu [États-Unis] ; Jens C. Krause [États-Unis] ; Ryan Mcbride [États-Unis] ; James C. Paulson [États-Unis] ; James E. Crowe [États-Unis] ; Ian A. Wilson [États-Unis]A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin
000F07 (2010) Ji-Young Min [États-Unis] ; Leatrice Vogel ; Yumiko Matsuoka ; Bin Lu ; David Swayne ; Hong Jin ; George Kemble ; Kanta SubbaraoA live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
000355 (2017) Troy C. Sutton [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Kevin W. Bock [États-Unis] ; Ian N. Moore [États-Unis] ; Wouter Koudstaal [Pays-Bas] ; Muniza Rehman [Pays-Bas] ; Gerrit Jan Weverling [Pays-Bas] ; Jaap Goudsmit [Pays-Bas] ; Kanta Subbarao [États-Unis]In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice
000653 (2014) Simon E. Hufton [Royaume-Uni] ; Paul Risley [Royaume-Uni] ; Christina R. Ball [Royaume-Uni] ; Diane Major [Royaume-Uni] ; Othmar G. Engelhardt [Royaume-Uni] ; Stephen Poole [Royaume-Uni]The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
000825 (2013) Cyrille Dreyfus ; Damian C. Ekiert ; Ian A. WilsonStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
000A50 (2012) Nicola Clementi ; Elena Criscuolo ; Matteo Castelli ; Nicasio Mancini ; Massimo Clementi ; Roberto BurioniInfluenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines
000A76 (2012) Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. RudenkoComparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
000B49 (2012) Jenny Aurielle B. Babon [États-Unis] ; John Cruz [États-Unis] ; Francis A. Ennis [États-Unis] ; LIUSONG YIN [États-Unis] ; Masanori Terajima [États-Unis]A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus
000D60 (2011) Nobuko Ohshima [Japon] ; Yoshitaka Iba [Japon] ; Ritsuko Kubota-Koketsu [Japon] ; Yoshizo Asano [Japon] ; Yoshinobu Okuno [Japon] ; Yoshikazu Kurosawa [Japon]Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5
001744 (2002) Emi Tsuchiya ; Kanetsu Sugawara ; Seiji Hongo ; Yoko Matsuzaki ; Yasushi Muraki ; Kiyoto NakamuraRole of overlapping glycosylation sequons in antigenic properties, intracellular transport and biological activities of influenza A/H2N2 virus haemagglutinin.
002D80 (????) E Iu Boravleva ; N F Lomakina ; E A Kropotkina ; I A Rudneva ; S S Iamnikova ; L G Rudenko ; V V Drygin ; A S Gambarian[The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2].
000042 (2019) M. Linster [Pays-Bas, Singapour] ; E. J. A. Schrauwen [Pays-Bas] ; S. Van Der Vliet [Pays-Bas] ; D. F. Burke [Royaume-Uni] ; P. Lexmond [Pays-Bas] ; T. M. Bestebroer [Pays-Bas] ; D. J. Smith [Royaume-Uni] ; S. Herfst [Pays-Bas] ; B. F. Koel [Pays-Bas] ; R. A. M. Fouchier [Pays-Bas]The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses
000087 (2019) Z Beau Reneer [États-Unis] ; Ted M. Ross [États-Unis]H2 influenza viruses: designing vaccines against future H2 pandemics.
000160 (2018) Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000259 (2017) Robert P. De Vries [États-Unis, Pays-Bas] ; Wenjie Peng [États-Unis] ; Oliver C. Grant [États-Unis] ; Andrew J. Thompson [États-Unis] ; Xueyong Zhu [États-Unis] ; Kim M. Bouwman [Pays-Bas] ; Alba T. Torrents De La Pena [Pays-Bas] ; Marielle J. Van Breemen [Pays-Bas] ; Iresha N. Ambepitiya Wickramasinghe [Pays-Bas] ; Cornelis A. M. De Haan [Pays-Bas] ; Wenli Yu [États-Unis] ; Ryan Mcbride [États-Unis] ; Rogier W. Sanders [Pays-Bas, États-Unis] ; Robert J. Woods [États-Unis] ; Monique H. Verheije [Pays-Bas] ; Ian A. Wilson [États-Unis] ; James C. Paulson [États-Unis]Three mutations switch H7N9 influenza to human-type receptor specificity
000829 (2013) Hua Yang ; Paul J. Carney ; Jessie C. Chang ; Julie M. Villanueva ; James StevensStructural Analysis of the Hemagglutinin from the Recent 2013 H7N9 Influenza Virus
000B46 (2012) Jens C. Krause [États-Unis] ; Tshidi Tsibane [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Chelsey J. Huffman [États-Unis] ; Randy Albrecht [États-Unis] ; David L. Blum [États-Unis] ; Irene Ramos [États-Unis] ; Ana Fernandez-Sesma [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Christopher F. Basler [États-Unis] ; James E. Jr Crowe [États-Unis]Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
000B97 (2011) Guus F. Rimmelzwaan [Pays-Bas] ; Rogier Bodewes ; Albert D M E. OsterhausVaccination strategies to protect children against seasonal and pandemic influenza.
001041 (2009) Rui Xu ; Ryan Mcbride ; James C. Paulson ; Christopher F. Basler ; Ian A. WilsonStructure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic▿ †
001121 (2009) Reiko Yoshida [Japon] ; Manabu Igarashi ; Hiroichi Ozaki ; Noriko Kishida ; Daisuke Tomabechi ; Hiroshi Kida ; Kimihito Ito ; Ayato TakadaCross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
001251 (2008) Manabu Igarashi [Japon] ; Kimihito Ito ; Hiroshi Kida ; Ayato TakadaGenetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
002D97 (????) I V Kiseleva ; E A Bazhenova ; N V Larionova ; E A Fedorova ; I A Dubrovina ; I N Isakova-Sivak ; L G Rudenko[Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
002E11 (????) L A Stepanova ; A A Kovaleva ; M V Potapchuk ; A V Korotkov ; V V Kupriianov ; E A Blokhina ; R Iu Kotliarov ; L M Tsybalova[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
002E26 (????) T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
002E38 (????) O S Kashirina ; M I Chernikova ; Yu M. Vasiliev[COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA].
000220 (2018) Guo Luo ; Aditya Ambati ; Ling Lin ; Mélodie Bonvalet ; Markku Partinen [Finlande] ; Xuhuai Ji ; Holden Terry Maecker ; Emmanuel Jean-Marie MignotAutoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy
000286 (2017) Zhu-Nan Li [États-Unis] ; Jessica F. Trost [États-Unis] ; Kimberly M. Weber [États-Unis] ; Elizabeth H. Lemasters [États-Unis] ; Sharifa Nasreen [Bangladesh] ; Javan Esfandiari [États-Unis] ; Angelo H. Gunasekera [États-Unis] ; Megan Mccausland [États-Unis] ; Katharine Sturm-Ramirez [États-Unis] ; Jens Wrammert [États-Unis] ; Sean Gregory [États-Unis] ; Vic Veguilla [États-Unis] ; James Stevens [États-Unis] ; Joseph D. Miller [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Min Z. Levine [États-Unis]Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.
000470 (2016) Naomi Komadina [Australie] ; Sergio M. Qui Ones-Parra [Australie] ; Katherine Kedzierska [Australie] ; James M. Mccaw [Australie] ; Anne Kelso [Australie] ; Karin Leder [Australie] ; Jodie Mcvernon [Australie]High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant
000520 (2015) Petr Chlanda [Allemagne] ; Oliver Schraidt [Allemagne] ; Susann Kummer [Allemagne] ; James Riches [Allemagne] ; Heike Oberwinkler [Allemagne] ; Simone Prinz [Allemagne] ; Hans-Georg Kr Usslich [Allemagne] ; John A G. Briggs [Allemagne]Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology.
000529 (2015) Zhong-Wei Zhang [République populaire de Chine] ; Ting Liu [République populaire de Chine] ; Jian Zeng [République populaire de Chine] ; Yang-Er Chen [République populaire de Chine, Suède] ; Ming Yuan [République populaire de Chine, États-Unis] ; Da-Wei Zhang [République populaire de Chine, États-Unis] ; Feng Zhu [République populaire de Chine] ; Shu Yuan [République populaire de Chine]Prediction of the next highly pathogenic avian influenza pandemic that can cause illness in humans
000565 (2015) Ankita Malik [Inde] ; V Vamsee Aditya Mallajosyula [Inde] ; Nripendra Nath Mishra [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.
000589 (2015) Claudia Pappas ; Hua Yang ; Paul J. Carney ; Melissa B. Pearce ; Jacqueline M. Katz ; James Stevens ; Terrence M. TumpeyAssessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets
000741 (2014) Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis]Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model
000849 (2013) Rui Xu [États-Unis] ; Robert P. De Vries [États-Unis] ; Xueyong Zhu [États-Unis] ; Corwin M. Nycholat [États-Unis] ; Ryan Mcbride [États-Unis] ; Wenli Yu [États-Unis] ; James C. Paulson [États-Unis] ; Ian A. Wilson [États-Unis]Preferential recognition of avian-like receptors in human influenza A H7N9 viruses
000859 (2013) Matthew S. Miller [États-Unis] ; Thomas J. Gardner [États-Unis] ; Florian Krammer [États-Unis] ; Lauren C. Aguado [États-Unis] ; Domenico Tortorella [États-Unis] ; Christopher F. Basler [États-Unis] ; Peter Palese [États-Unis]Neutralizing antibodies against previously-encountered influenza virus strains increase over time: A longitudinal analysis
000921 (2013) Manasa V. Gudheti [États-Unis] ; Nikki M. Curthoys ; Travis J. Gould ; Dahan Kim ; Mudalige S. Gunewardene ; Kristin A. Gabor ; Julie A. Gosse ; Carol H. Kim ; Joshua Zimmerberg ; Samuel T. HessActin mediates the nanoscale membrane organization of the clustered membrane protein influenza hemagglutinin.
000A23 (2012) Jianzhong Shi [République populaire de Chine] ; Zhiyuan Wen ; Jing Guo ; Ying Zhang ; Guohua Deng ; Yuelong Shu ; Dayan Wang ; Yongping Jiang ; Yoshihiro Kawaoka [États-Unis] ; Zhigao Bu ; Hualan ChenProtective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
000A85 (2012) Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta SubbaraoAn open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000C34 (2011) Yanwei Zhong [République populaire de Chine] ; Jiong Cai [République populaire de Chine] ; Chuanfu Zhang [République populaire de Chine] ; Xiaoyan Xing [République populaire de Chine] ; Enqiang Qin [République populaire de Chine] ; Jing He [République populaire de Chine] ; Panyong Mao [République populaire de Chine] ; Jun Cheng [République populaire de Chine] ; Kun Liu [République populaire de Chine] ; Dongping Xu [République populaire de Chine] ; Hongbin Song [République populaire de Chine]Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A
000E24 (2010) Ana Clara Monsalvo [Argentine] ; Juan P. Batalle [Argentine] ; M. Florencia Lopez [Argentine] ; Jens C. Krause [États-Unis] ; Jennifer Klemenc [États-Unis] ; Johanna Zea [Argentine, États-Unis] ; Bernardo Maskin [Argentine] ; Jimena Bugna [Argentine] ; Carlos Rubinstein [Argentine] ; Leandro Aguilar [Argentine] ; Liliana Dalurzo [Argentine] ; Romina Libster [Argentine] ; Vilma Savy [Argentine] ; Elsa Baumeister [Argentine] ; Liliana Aguilar [Argentine] ; Graciela Cabral [Argentine] ; Julia Font [Argentine] ; Liliana Solari [Argentine] ; Kevin P. Weller [États-Unis] ; Joyce Johnson [États-Unis] ; Marcela Echavarria [Argentine] ; Kathryn M. Edwards [États-Unis] ; James D. Chappell [États-Unis] ; James E. Crowe [États-Unis] ; John V. Williams [États-Unis] ; Guillermina A. Melendi [Argentine, États-Unis] ; Fernando P. Polack [Argentine, États-Unis]Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
000E31 (2010) Claudia Pappas [États-Unis] ; Karthik Viswanathan [États-Unis] ; Aarthi Chandrasekaran [États-Unis] ; Rahul Raman [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Ram Sasisekharan [États-Unis] ; Terrence M. Tumpey [États-Unis]Receptor Specificity and Transmission of H2N2 Subtype Viruses Isolated from the Pandemic of 1957
000F22 (2010) Jiankui He ; Michael W. Deem [États-Unis]Low-dimensional clustering detects incipient dominant influenza strain clusters
001227 (2008) James Stevens [États-Unis] ; Ola Blixt [États-Unis] ; Li-Mei Chen [États-Unis] ; Ruben O. Donis [États-Unis] ; James C. Paulson [États-Unis] ; Ian A. Wilson [États-Unis]Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity
001516 (2006) Edwin D. KilbourneInfluenza Immunity: New Insights from Old Studies
001536 (2006) Laurel Glaser [États-Unis] ; Dmitriy Zamarin [États-Unis] ; Helen M. Acland [États-Unis] ; Erica Spackman [États-Unis] ; Peter Palese [États-Unis] ; Adolfo García-Sastre [États-Unis] ; Deepanker Tewari [États-Unis]Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North America
001569 (2006) J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis]Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential
001653 (2004) Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima YouilProtective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
001751 (2002) Christoph Scholtissek ; Jürgen Stech ; Scott Krauss ; Robert G. WebsterCooperation between the Hemagglutinin of Avian Viruses and the Matrix Protein of Human Influenza A Viruses
001807 (2001) Emi Tsuchiya ; Kanetsu Sugawara ; Seiji Hongo ; Yoko Matsuzaki ; Yasushi Muraki ; Zhu-Nan Li ; Kiyoto NakamuraAntigenic structure of the haemagglutinin of human influenza A/H2N2 virus.
001872 (2001) M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie]Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice
001878 (2001) Mikhail N. Matrosovich ; Scott Krauss ; Robert G. WebsterH9N2 Influenza A Viruses from Poultry in Asia Have Human Virus-like Receptor Specificity
001904 (2000) Mikhail Matrosovich ; Alexander Tuzikov ; Nikolai Bovin ; Alexandra Gambaryan ; Alexander Klimov ; Maria R. Castrucci ; Isabella Donatelli ; Yoshihiro Kawaoka [États-Unis]Early Alterations of the Receptor-Binding Properties of H1, H2, and H3 Avian Influenza Virus Hemagglutinins after Their Introduction into Mammals
002352 (1986) Tadao Sonoguchi [Japon] ; Mitsuo Sakoh [Japon] ; Nobuharu Kunita [Japon] ; Kiyoaki Satsuta [Japon] ; Hideo Noriki [Japon] ; Hideo Fukumi [Japon]Reinfection with Influenza A (H2N2, H3N2, and H1N1) Viruses in Soldiers and Students in Japan
002498 (1984) N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon]Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
002567 (1983) M L Clements ; S. O'Donnell ; M M Levine ; R M Chanock ; B R MurphyDose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
002614 (1983) C. W. Potter [Royaume-Uni] ; R. Jennings [Royaume-Uni] ; A. Clark [Royaume-Uni] ; M. Ali [Royaume-Uni]Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers
002D84 (????) E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
002E18 (????) A N Na Khin ; S A Donina ; G D Petukhova ; E M Koren'Kov ; E M Doroshenko ; E P Grigor'Eva ; M A Suvorova ; L G Rudenko[Humoral and cell-mediated immune responses in humans to the A/California/07/ 2009 (H1N1) virus, A(H1N1)pdm2009].
002E55 (????) A. Malik [Inde] ; Vva Mallajosyula [Inde] ; N N Mishra [Inde] ; A P Arukha [Inde] ; R. Varadarajan [Inde] ; S K Gupta [Inde]Generation and characterisation of monoclonal antibodies specific to avian influenza H7N9 haemagglutinin protein.
000125 (2018-04) Tomi Sarkanen ; Anniina P. E. Alakuijala ; Yves Dauvilliers [France] ; Markku PartinenIncidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis
000128 (2018-03) V. Busignies [France] ; G. Simon [France] ; G. Mollereau [France] ; O. Bourry [France] ; V. Mazel [France] ; Manuel Rosa-Calatrava [France] ; P. Tchoreloff [France]Development and pre-clinical evaluation in the swine model of a mucosal vaccine tablet for human influenza viruses: A proof-of-concept study
000166 (2018) Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik PeirisPopulation Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
000168 (2018) Alain Gagnon [Canada] ; Enrique Acosta [Canada] ; Stacey Hallman [Canada] ; Robert Bourbeau [Canada] ; Lisa Y. Dillon [Canada] ; Nadine Ouellette [Canada] ; David J. D. Earn [Canada] ; D. Ann Herring [Canada] ; Kris Inwood [Canada] ; Joaquin Madrenas [États-Unis] ; Matthew S. Miller [Canada]Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic
000176 (2018) Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines
000212 (2018) Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Marina A. Shuklina [Russie] ; Eugenia S. Mardanova [Russie] ; Roman Y. Kotlyarov [Russie] ; Marina V. Potapchuk [Russie] ; Sergei A. Petrov [Russie] ; Elena A. Blokhina [Russie] ; Nikolai V. Ravin [Russie]Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
000305 (2017) Dennis E. Te Beest [Pays-Bas] ; Erwin De Bruin [Pays-Bas] ; Sandra Imholz [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Michiel Van Boven [Pays-Bas]Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)
000342 (2017) S. Kannan [Inde] ; P. Kolandaivel [Inde]Antiviral potential of natural compounds against influenza virus hemagglutinin.
000377 (2016-07) Stéphanie Fougerolle [France] ; Loïc Legrand [France] ; Dion Garrett [Royaume-Uni] ; Ilhan Birand [Royaume-Uni] ; Marc Foursin [France] ; Xavier D Blon [France] ; Pierre Bayssat [France] ; Richard Newton [Royaume-Uni] ; Stéphane Pronost [France] ; Romain Paillot [Royaume-Uni]Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals
000389 (2016) Paul Loubet [France] ; Nezha Samih-Lenzi [France] ; Florence Galtier [France] ; Philippe Vanhems [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Stéphane Jouneau [France] ; Déborah Postil [France] ; Sylvie Rogez [France] ; Martine Valette [France] ; Corinne Merle [France] ; Corinne Régis [France] ; Yolande Costa [France] ; Zineb Lesieur [France] ; Pierre Tattevin [France] ; Bruno Lina [France] ; Fabrice Carrat [France] ; Odile Launay [France]Factors associated with poor outcomes among adults hospitalised for influenza in France: A three-year prospective multicenter study
000449 (2016) J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie]H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
000465 (2016) Sergio M. Qui Ones-Parra [Australie] ; E. Bridie Clemens [Australie] ; Zhongfang Wang [Australie] ; Hayley A. Croom [Australie] ; Lukasz Kedzierski [Australie] ; Jodie Mcvernon [Australie] ; Dhanasekaran Vijaykrishna [Singapour] ; Katherine Kedzierska [Australie]A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses
000498 (2015) A V Lyapunov ; S I Kolesnikov ; M A Khasnatinov ; E L Manzarova ; I V Petrova ; V V Dolgikh ; G A Danchinova[Child and Adolescent Interepydemic Immunity to Influenza Viruses].
000513 (2015) Daniel Dlugolenski [États-Unis] ; Les Jones [États-Unis] ; Elizabeth Howerth [États-Unis] ; David Wentworth [États-Unis] ; S. Mark Tompkins [États-Unis] ; Ralph A. Tripp [États-Unis]Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression
000522 (2015) Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
000563 (2015) Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
000674 (2014) Andrew J. Broadbent [États-Unis] ; Celia P. Santos [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; Janine Lu [États-Unis] ; Zhongying Chen [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [États-Unis]Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates
000679 (2014) Caroline M. Mair [Allemagne] ; Kai Ludwig [Allemagne] ; Andreas Herrmann [Allemagne] ; Christian Sieben [Allemagne]Receptor binding and pH stability - how influenza A virus hemagglutinin affects host-specific virus infection.
000739 (2014) Mai-Juan Ma [République populaire de Chine] ; Xiao-Xian Yang [République populaire de Chine] ; Yan-Hua Qian [République populaire de Chine] ; Si-Yan Zhao [République populaire de Chine] ; Sha Hua [République populaire de Chine] ; Tie-Cheng Wang [République populaire de Chine] ; Shan-Hui Chen [République populaire de Chine] ; Guang-Yuan Ma [République populaire de Chine] ; Xiao-Yu Sang [République populaire de Chine] ; Lin-Na Liu [République populaire de Chine] ; Ai-Ping Wu [République populaire de Chine] ; Tai-Jiao Jiang [République populaire de Chine] ; Yu-Wei Gao [République populaire de Chine] ; Gregory C. Gray [États-Unis] ; Teng Zhao [République populaire de Chine] ; Xia Ling [République populaire de Chine] ; Jing-Lin Wang [République populaire de Chine] ; Bing Lu [République populaire de Chine] ; Jun Qian [République populaire de Chine] ; Wu-Chun Cao [République populaire de Chine]Characterization of a Novel Reassortant Influenza A Virus (H2N2) from a Domestic Duck in Eastern China
000963 (2013) M. Panning [Allemagne]Influenza heute und in Zukunft
000A62 (2012) Masanori Terajima ; Jenny Aurielle B. Babon ; Francis A. EnnisEpidemiology of the Influenza A Virus H5N1 Subtype and Memory of Immunity to the H2N2 Subtype
000B99 (2011) Geneviève Girard [Pays-Bas] ; Alexander P. Gultyaev ; René C L. OlsthoornUpstream start codon in segment 4 of North American H2 avian influenza A viruses.
000C37 (2011) Kristian M. Hargadon [États-Unis] ; Haixia Zhou ; Randy A. Albrecht ; Haley A. Dodd ; Adolfo García-Sastre ; Thomas J. BracialeMajor histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells.
000D63 (2011) Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada]Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age
000D93 (2010) N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
000E59 (2010) Philippe R S. Lagacé-Wiens [Canada] ; Ethan Rubinstein ; Abba GumelInfluenza epidemiology--past, present, and future.
000E85 (2010) Pierre Van Damme [Belgique] ; Robert Arnou ; Froukje Kafeja ; Anne Fiquet ; Patrick Richard ; Stéphane Thomas ; Gilles Meghlaoui ; Sandrine Isabelle Samson ; Emilio LedesmaEvaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.
000E90 (2010) Karthik Viswanathan [États-Unis] ; Xiaoying Koh [États-Unis] ; Aarthi Chandrasekaran [États-Unis] ; Claudia Pappas [États-Unis] ; Rahul Raman [États-Unis] ; Aravind Srinivasan [États-Unis] ; Zachary Shriver [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Ram Sasisekharan [États-Unis]Determinants of Glycan Receptor Specificity of H2N2 Influenza A Virus Hemagglutinin
000F05 (2010) Alicia Sol Rzano [États-Unis] ; Jianqiang Ye [États-Unis] ; Daniel R. Pérez [États-Unis]Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu▿
000F91 (2010) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Chin-Fen Yang [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets
001030 (2009) Amorsolo L. Suguitan ; Michael P. Marino ; Purvi D. Desai ; Li-Mei Chen ; Yumiko Matsuoka ; Ruben O. Donis ; Hong Jin ; David E. Swayne ; George Kemble ; Kanta SubbaraoThe influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus
001060 (2009) Lauren J. Dimenna [États-Unis] ; Hildegund C J. ErtlPandemic influenza vaccines.
001087 (2009) Shufang Fan [République populaire de Chine] ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka [États-Unis] ; Hualan ChenImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
001091 (2009) Shanta M. Zimmer [États-Unis] ; Donald S. BurkeHistorical perspective--Emergence of influenza A (H1N1) viruses.
001220 (2008) Lisa M. Alleva [Australie] ; Alison C. Budd ; Ian A. ClarkSystemic release of high mobility group box 1 protein during severe murine influenza.
001243 (2008) R J Green [Afrique du Sud] ; C. Feldman ; B. Schoub ; G A Richards ; S A Madhi ; H J Zar ; U. Lalloo ; K. Klugman ; D. Phillips ; N A Cameron ; R R EggersInfluenza guideline for South Africa--update 2008.
001250 (2008) Michelle Roti [États-Unis] ; Junbao Yang ; Deanna Berger ; Laurie Huston ; Eddie A. James ; William W. KwokHealthy human subjects have CD4+ T cells directed against H5N1 influenza virus.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021